TA186: Rheumatoid arthritis - certolizumab pegol
This is a discussion on TA186: Rheumatoid arthritis - certolizumab pegol within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Rheumatoid arthritis - certolizumab pegol. It links to the published guidance and key ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
02-23-2010, 08:40 PM
|
|||
|
|||
TA186: Rheumatoid arthritis - certolizumab pegol
The summary for the published technology appraisal on Rheumatoid arthritis - certolizumab pegol. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Certolizumab Maintains Efficacy for 2 Years in Rheumatoid Arthritis Patients | industry_news | Other Clinical Pharmacy News | 0 | 10-31-2008 11:15 PM |
| Risk of MI Doubled in Patients With Rheumatoid Arthritis | industry_news | Other Clinical Pharmacy News | 0 | 10-10-2008 07:19 PM |
| Rheumatoid Arthritis Severity Linked to Stroke | industry_news | Other Clinical Pharmacy News | 0 | 09-08-2008 07:19 PM |
| Adalimumab May Be Helpful for Juvenile Rheumatoid Arthritis | industry_news | Other Clinical Pharmacy News | 0 | 08-25-2008 06:09 PM |
| Everolimus Effective in Rheumatoid Arthritis Patients | industry_news | Other Clinical Pharmacy News | 0 | 08-12-2008 07:06 AM |
© 2008 DrugManagementForum™ powered by |
 |